Worth reading
8Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
5000
INR 10,000 (capital)Wording
Definitive
How definitive the wording is.Items stated in the management plan
Key initiatives
01Strengthening the Overseas Business
02Rapid product registration and establishment of a sales structure
03Stable supply of Japanese quality (“Designed in Japan”)
04Accelerating regulatory and sales processes
05Promoting clinical evaluation
06Strengthening education and services
Plan assumptionsIndia’s medical device market is expected to expand rapidly alongside the country’s sharp population and economic growth.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan |
| Plan assumptions | India’s medical device market is expected to expand rapidly alongside the country’s sharp population and economic growth. |
| Key initiatives | Strengthening the Overseas Business, Rapid product registration and establishment of a sales structure, Stable supply of Japanese quality (“Designed in Japan”), Accelerating regulatory and sales processes, Promoting clinical evaluation, Strengthening education and services |
| Publication date | 19 March 2026 |
Items this document does not state (21)
Plan periodProgress against the planSales TargetOperating profit targetOperating profit margin targetNet income targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetNon-financial targetsResults under the previous planReason for revision or withdrawalSize of the Target MarketRisks identifiedDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company is pursuing market development in India and Southeast Asia under the key measure of strengthening its overseas business in its Medium-Term Management Plan. The subsidiary will capture the expansion of the Indian market, enable the rapid registration of products and establishment of a sales structure, and achieve a stable supply of “Japanese quality (Designed in Japan).”
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.